About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Pennsylvania | 893 Studies

Clinical Trials Lung CancerPennsylvania

Lung Cancer Clinical Trials in Pennsylvania

Find 893 clinical trials for lung cancer near Pennsylvania. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 501-520 of 893 trials

Active not recruitingPhase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLCWhile cigarette smoking remains the primary cause of most lung cancer cases, lung carcinoma in never smokers account for nearly 20 percent of cases.NCT03786692·Philadelphia, Pennsylvania TerminatedTrial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain MetastasesThis is an open-label phase II clinical trial designed to allow a preliminary assessment of the efficacy and safety of cabozantinib in unselected Non-Small Cell Lung Cancer…NCT02132598·Pittsburgh, Pennsylvania

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedTesting the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung CancerThis trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable…NCT04878952·Chambersburg, Pennsylvania and 4 others

TerminatedA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsThis is a first in human (FIH) 2-part study using ACTM-838 in patients with advanced solid tumors resistant to standard of care treatment.NCT06336148·Los Angeles, California and 4 others

RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationThe purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors.NCT05059444·Birmingham, Alabama and 56 others

TerminatedPredictive Assay for Decision Making in Adjuvant TherapyProspective Registrational Trial to Define Real World Outcomes of Patients with Completely Resected Stage I or IIA (tumor \< or = 5cm, node negative) Non-squamous Non-Small Lung…NCT05032352·Duarte, California and 17 others

CompletedMK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride TherapyThis phase II trial studies the side effects and how well Akt inhibitor MK2206 (MK2206) and erlotinib hydrochloride works in treating patients with advanced non-small cell lung…NCT01294306·Beverly Hills, California and 6 others

CompletedImproving Resection Rates Among African Americans With NSCLCThis is a randomized, interventional trial in which the navigation is the intervention. Phase is not applicable.NCT01885455·Lewes, Delaware and 9 others

TerminatedPembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung CancerThis is a single center, single arm phase 2 study to establish the safety and efficacy of itacitinib (also known as INCB039110) administered in combination with pembrolizumab in…NCT03425006·Philadelphia, Pennsylvania

TerminatedGRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)The purpose of this study is to assess the efficacy, safety, and tolerability of GRN1005 in patients with brain metastases from non-small cell lung cancer (NSCLC).NCT01497665·La Jolla, California and 9 others

Approved for marketingAfatinib Expanded Access ProgramThis is an open-label, multi-center, single-arm trial, designed to provide early access to afatinib and to provide additional information on the safety and efficacy of afatinib in…NCT01649284·Mobile, Alabama and 65 others

CompletedA Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)This randomized, open-label study evaluated the safety and efficacy of atezolizumab (an engineered anti-programmed death-ligand 1 \[PD-L1\] antibody) in combination with…NCT02366143·Chandler, Arizona and 239 others

RecruitingFirst-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion MutationsStudy STX-721-101/PFL-721CI101 is an open label, Phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (PK) exposure, and preliminary antitumor activity of…NCT06043817·Duarte, California and 24 others

RecruitingA Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCThe goal of this clinical trial is to learn about the safety and recommended dose of TRI-611 when administered to adults with ALK-positive non-small cell lung cancer (NSCLC).NCT07491497·San Francisco, California and 15 others

CompletedA Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsTaxotere has been approved by the FDA and is considered a standard treatment for patients with lung cancer who have failed prior platinum-containing regimens.NCT00085826·Birmingham, Alabama and 113 others

CompletedCarboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerThis randomized phase II trial is studying how well giving carboplatin and paclitaxel together with cetuximab and/or cixutumumab (IMC-A12) works in treating patients with stage…NCT00986674·Stanford, California and 248 others

CompletedA Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsThe purpose of this study is to assess the safety and tolerability of ASP8273 and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D).NCT02113813·Washington D.C., District of Columbia and 11 others

Active not recruitingA Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsThis study will compare Valemetostat Tosylate Plus Pembrolizumab vs Pembrolizumab Alone in First-line NSCLC Without Actionable Genomic AlterationsNCT06644768·La Jolla, California and 34 others

CompletedAn Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced CancersA study to evaluate the safety of Nivolumab given in combination with Ipilimumab in patients with advanced cancers.NCT02869789·Birmingham, Alabama and 135 others

CompletedEvaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerThis study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in…NCT00050960·Montgomery, Alabama and 153 others

PreviousPage 26 of 45Next

Other Conditions in Pennsylvania

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma